Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis

Journal of Infectious Diseases

Volumn 196, Issue 9, 2007, Pages 1425-1430

  Stryjewski, Martin E ^a,b,f   Hall, Russell P ^a   Chu, Vivian H ^a   Kanafani, Zeina A ^a   O'Riordan, William D ^c   Weinstock, Michael S ^d   Stienecker, R Scott ^e   Streilein, Robert ^a   Dorschner, Robert A ^c   Fowler Jr , Vance G ^a   Corey, G Ralph ^a   Gallo, Richard L ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Intensive Care Unit   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LEHIGH VALLEY HOSPITAL   (United States)

^e Regional Infectious Diseases Infusion Center Inc   (United States)

^f NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA DEFENSIN 2; CATHELICIDIN; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; DEFB4 PROTEIN, HUMAN; INTERLEUKIN 6; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; BLOOD; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; SKIN;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CELLULITIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RNA, MESSENGER; SKIN;

EID: 38449106907     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522630     Document Type: Article

References (15)

1. Gallo RL, Murakami M, Ohtake T, Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002; 110:823-31.
2. Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 2005; 125:9-13.
3. Braff MH, Zaiou M, Fierer J, Nizet V, Gallo RL. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect Immun 2005; 73:6771-81.
4. Nizet V, Ohtake T, Lauth X, et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414:454-7.
5. Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004; 111:273-81.
6. Putsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002; 360:1144-9.
7. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347:1151-60.
8. Chronnell CM, Ghali LR, Ali RS, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol 2001; 117:1120-5.
9. Oono T, Huh WK, Shirafuji Y, Akiyama H, Iwatsuki K. Localization of human beta-defensin-2 and human neutrophil peptides in superficial folliculitis. Br J Dermatol 2003; 148:188-91.
10. Stryjewski ME, O'Riordan WD, Lau WK, et al. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. Clin Infect Dis 2005; 40:1601-7.
11. Lee PH, Ohtake T, Zaiou M, et al. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci USA 2005; 102:3750-5.
12. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth 1996; 77:110-7.
13. Wu H, Zhang G, Minton JE, Ross CR, Blecha F. Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar Typhimurium infection. Infect Immun 2000; 68:5552-8.
14. Wehkamp K, Schwichtenberg L, Schroder JM, Harder J. Pseudomonas aeruginosa- and IL-1β-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-κB and AP-1. J Invest Dermatol 2006; 126:121-7.
15. + Tregs: limiting collateral damage. J Clin Invest 2004; 114:1372-8.